osimertinib
astrazeneca
['adaura', 'osimertinib', 'aura ,(-laura)']
2. presented at #asco23, osimertinib in phase iii adaura study showed a dfs benefit vs placebo. stage ii iiia dfs hazard ratio (hr) was an impressive 0.23! #osimertinib #dfs #health
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer